Clinical Trial Detail

NCT ID NCT01737502
Title PKCi and mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Mayo Clinic
Indications

lung small cell carcinoma

lung adenocarcinoma

lung squamous cell carcinoma

Therapies

Auranofin + Sirolimus

Age Groups: adult

Additional content available in CKB BOOST